Statement Of Changes In Equity [Abstract]

Xbrane Biopharma - Filing #679209

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	171 335 SEK	1 273 999 SEK	—	—	—	6 683 SEK	10 121 SEK	—	1 428 530 SEK	424 888 SEK	—	—	—	885 827 SEK	6 166 SEK	10 322 SEK	1 294 227 SEK	—	—	713 313 SEK	1 134 276 SEK	431 741 SEK	5 165 SEK	5 614 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	388 172 SEK	—	—	388 172 SEK	—	—	—	—	—	—	—	—	172 513 SEK	172 513 SEK	—	—	—	—	—	—	—	—	—	—	—
Other comprehensive income	201,000 SEK	—	—	—	201,000 SEK	—	—	—	—	—	—	—	5 157 SEK	—	—	—	—	—	5 157 SEK	—	—	—	—	—	—
Comprehensive income	388 373 SEK	—	—	388 172 SEK	201,000 SEK	0 SEK	—	—	0 SEK	—	—	– SEK	167 356 SEK	172 513 SEK	—	—	—	—	5 157 SEK	– SEK	—	—	—	—	—
Issue of equity	132 830 SEK	—	—	—	—	517,000 SEK	—	—	132 314 SEK	—	—	551,000 SEK	170 551 SEK	—	—	—	—	—	—	170 000 SEK	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	2 952 SEK	—	—	—	—	—	—	—	2 952 SEK	—	—	—	3 301 SEK	—	—	—	—	—	—	3 301 SEK	—	—	—	—	—